NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Galecto Inc (NASDAQ: GLTO)
GLTO Technical Analysis
1.5
As on 9th Jun 2023 GLTO STOCK Price closed @ 2.19 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.06 & Sell for SHORT-TERM with Stoploss of 2.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GLTOSTOCK Price
Open | 2.30 | Change | Price | % |
High | 2.30 | 1 Day | -0.04 | -1.79 |
Low | 2.16 | 1 Week | -0.05 | -2.23 |
Close | 2.19 | 1 Month | 0.28 | 14.66 |
Volume | 29510 | 1 Year | -0.63 | -22.34 |
52 Week High 3.45 | 52 Week Low 1.06 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
GLTO Daily Charts |
GLTO Intraday Charts |
Whats New @ Bazaartrend |
GLTO Free Analysis |
|
GLTO Important Levels Intraday
RESISTANCE | 2.46 |
RESISTANCE | 2.37 |
RESISTANCE | 2.32 |
RESISTANCE | 2.27 |
SUPPORT | 2.11 |
SUPPORT | 2.06 |
SUPPORT | 2.01 |
SUPPORT | 1.92 |
GLTO Forecast May 2024
4th UP Forecast | 4.68 |
3rd UP Forecast | 3.88 |
2nd UP Forecast | 3.39 |
1st UP Forecast | 2.89 |
1st DOWN Forecast | 1.49 |
2nd DOWN Forecast | 0.99 |
3rd DOWN Forecast | 0.5 |
4th DOWN Forecast | -0.3 |
GLTO Weekly Forecast
4th UP Forecast | 3.37 |
3rd UP Forecast | 2.99 |
2nd UP Forecast | 2.76 |
1st UP Forecast | 2.52 |
1st DOWN Forecast | 1.86 |
2nd DOWN Forecast | 1.62 |
3rd DOWN Forecast | 1.39 |
4th DOWN Forecast | 1.01 |
GLTO Forecast2024
4th UP Forecast | 6.99 |
3rd UP Forecast | 5.45 |
2nd UP Forecast | 4.5 |
1st UP Forecast | 3.55 |
1st DOWN Forecast | 0.83 |
2nd DOWN Forecast | -0.12 |
3rd DOWN Forecast | -1.07 |
4th DOWN Forecast | -2.61 |
Galecto Inc ( NASDAQ USA Symbol : GLTO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GLTO Other Details
Segment | EQ | |
Market Capital | 84606824.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
GLTO Address
GLTO Latest News
GLTO Business Profile
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service